Careers Contact

Evaxion > Investors

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Evaxion expands AI-Immunology™ platform into autoimmune diseases

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

Evaxion provides update on MSD collaboration – retains global rights to Gonorrhea vaccine candidate EVX-B2

Upcoming events & presentations

Business update and full year 2025 financial results

Evaxion will provide a business update and report its full year 2025 financial results on Thursday, March 5, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. This event is free, open to the public and encouraged.

Latest events & presentations

Jan 12 – Jan 15, 2026

San Francisco, United States

18th Biotech Showcase

Coinciding with the 44th annual J.P. Morgan Healthcare Conference, Biotech Showcase takes place on January 12-14, 2026 in San Francisco, CA. It is a leading investor conference that connects private and micro-mid-cap biotech companies with investors and biopharma executives.

Q3

Latest quarterly report

View all financial reports

Presentation

Webcast

Transcript

Press release

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

Company presentation

Stay in touch

LinkedIn

Follow Evaxion on LinkedIn to engage, connect, and stay informed.

Twitter

Join the conversation and stay updated with Evaxion on X.

Subscribe to email news alerts

Join our mailing list to get our latest press releases delivered straight to your inbox.